AC-46484 - scopolamine-n-butylbromide | 149-64-4
Spiacenti, non è stato trovato nessun prodotto con riferimento AC-46484, ma La invitiamo a verificare i seguenti prodotti simili:
Hyoscine Butylbromide-d9 (N-Butyl Scopolamine Bromide-d9, N-Butyl Hyoscine Bromide-d9)
CAS:Formula:C21H21D9NO4·BrColore e forma:White To Off-White SolidPeso molecolare:369.53 79.90Hyoscine Butylbromide (N-Butyl Scopolamine Bromide, N-Butyl Hyoscine Bromide)
CAS:Formula:C21H30NO4·BrColore e forma:White To Off-White SolidPeso molecolare:360.47 79.90Buscopan
CAS:Formula:C21H30BrNO4Purezza:>98.0%(T)(HPLC)Colore e forma:White to Light yellow powder to crystalPeso molecolare:440.38Scopolamine Butylbromide
CAS:Formula:C21H30BrNO4Purezza:98%Colore e forma:SolidPeso molecolare:440.3712Ref: IN-DA007HY8
1g67,00€5g168,00€10g181,00€25gPrezzo su richiesta50gPrezzo su richiesta100mg56,00€250mg57,00€Scopolamine butylbromide
CAS:Formula:C21H30BrNO4Purezza:(Titration) 98.0 - 102.0 % (dried basis)Colore e forma:White or almost white crystalline powderPeso molecolare:440.37N-Butylscopolammonium Bromide-d9
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications N-Butylscopolammonium Bromide (B693752) acts as an anticholinergic and antispasmodic. This is the labeled analog.<br>References Lee, J.R., et al.: Clin. Radiol., 33, 273 (1982), Bauer, et al.: Arzneim.-Forsch., 18, 1132 (1986), Steger, A.C., et al.: Am. J. Gastroenterol., 81, 615 (1986),<br></p>Formula:C21H21D9NO4•BrColore e forma:Off-WhitePeso molecolare:369.52799HYOSCINE BUTYLBROMIDE CRS
CAS:HYOSCINE BUTYLBROMIDE CRSFormula:C21H30BrNO4Colore e forma:Crystalline Powder. White. Powder.Peso molecolare:440.3712HYOSCINE BUTYLBROMIDE FOR SYSTEM SUITABILITY CRS
CAS:HYOSCINE BUTYLBROMIDE FOR SYSTEM SUITABILITY CRSHyoscine butylbromide
CAS:Hyoscine butylbromideFormula:C21H30BrNO4Purezza:99.7%Colore e forma:WhitePeso molecolare:439.13582Scopolamine butylbromide, EP grade
CAS:Formula:C21H30BrNO4Purezza:≤ 0.10% (HPLC)Colore e forma:White or almost white crystalline powderPeso molecolare:440.37









